A review: Neuropharmacological screening techniques for pharmaceuticals

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 2, 2010, Pages 10-14

  Yadav, Yogesh Chand ^a   Jain, Avijeet ^b   Deb, Lokesh ^c  

^a K M SHAH DENTAL COLLEGE AND HOSPITAL   (India)

^b DR H S GOUR UNIVERSITY   (India)

^c INSTITUTE OF BIORESOURCES AND SUSTAINABLE DEVELOPMENT   (India)

Author keywords

Electro Shock (MES); Elevated plus maze; Muricide behaviour; Pentylenetetrazole (PTZ); Scopolamine; Shuttle box avoidance

Indexed keywords

AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; PENTETRAZOLE; PENTOBARBITAL; SCOPOLAMINE; SEDATIVE AGENT;

ALZHEIMER DISEASE; ANTICONVULSANT ACTIVITY; AVOIDANCE BEHAVIOR; DEMENTIA; DEPRESSION; DRUG SCREENING; ELECTRIC SHOCK; EPILEPSY; FORCED SWIMMING TEST; HUMAN; LEARNED HELPLESSNESS; LEARNING; MAZE TEST; MEMORY; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; REVIEW; TOXICITY TESTING; TRANQUILIZING ACTIVITY;

EID: 77953338076     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Seth SD. Textbook of pharmacology, published by Elsevier India private limited New Delhi 2005; 2rd edition: page no. 415.
2. Ruiz MH, Beltren YG, Mora S, Gabriela D, Glauce SB. Tortoriella J, Ramirez G. Antidepressant and anxiolytic effect of hydroalcoholic extract from Salvia elegans Journal of Ethnopharmacology, 2006: (article in press)
3. Suba V, Murugesan, Rao R.B, Pal M, Mandal SC, Saha B. Neuropharmacological profile of Barleria lupulina lindle extract in animal model. Journal of Ethnopharmacology, 2002; 81;251- 255.
4. Franco CIF, Morais LCSL, Quintans LJ, Almeida RN, Antonioui AR. CNS pharmacological effect of the hydroalcoholic extract of Sida cordifolia L. leaves, Journal of Ethnopharmacology, 2005; 98: 275-279.
5. Nabeshima, T. Behavioural aspects, of cholineigic transmission: role of basal forebrain cholinergic system in memory. Process in Brain Research 1993; 98: 405-411.
6. Higashida A, Ogawa N. Differences in the acquisition process and the effect of scopolarnine on radial maze performance in the strains of rats. Pharmacology Biochemistry and Behaviour 1987; 27: 483-489.
7. Sitararn N, Weingatiner H, Gillin, JC. Human serial learning, enhancement with arecholine and choline sad impairment with scopolamine. Science 1978; 201:247-276.
8. Shaji KS, Kishore NR, Lal KP, Prince M. Revealing a hidden problem. An evaluation of a community dementia case finding program from the Indian 10/66 dementia research network. International Journal of Geriatric Psychiatry 2002; 17, 222-225.
9. Kawas C, Gray S, Brookmeyer R., Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 2000; 54, 2072-2077.
10. Vas CJ, Pinto C, Panikker D, Noronha S, Deshpande N, Kulkarni L, Sachdeva S. Prevalence of dementia in an urban Man population. International Psychogeriatrics 2001; 13: 439-450.
11. Drachman and Leavitt. Human memory and the cholinergic system. Arch neural 1974; 30: 113-121.
12. Dilts SL, and Berry CA. Effect of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exper Ther 1967; 158: 279-285.
13. Glick SD, and Zimmerberg B. The amnesic effect of scopolamine.Behav.Biol 1972; 7: 245-254
14. Schindler U, Rush DK, Fielding S. Nootropic drug: animal model for study effect on conjetion. Drugs Devel Res, 1984; 4:567-576.
15. Iverson SD. Behavioural pharmacology of dementia. Naunyn schmiedeberg's. arch pharmacol 1998;288:suppl 2 R 371.
16. Darks AM, Oestreicher AB, Gispen WH, Isaakson RL. Behaviour and anatomical sequences of unilateral fornix lesion and administration of nimodipine. Brain res.1991; 557: 308-312.
17. Di Ciccod D, Anatal S, Ammassan Teule M. Prenatal to expose of gamma/neutran irridation; and sensory motor alternation and peridoxical effect on learning, teratology, 1991; 43:61-70.
18. Montgomery KC. the relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol 1958; 48: 254-260.
19. Pellow S, Chopin PH, File SE, Briley M. Validtion of open close arm entires in an elevated plus maze as a measure antiaxiety in rats. J Neurosci Meth 1981; 14: 149-169.
20. Capaldi EJ, and Capaldi ED. Aversive learning situation; apparatus and procedure; in RD Meyer (ed) methods in psychobiology 1972; 2: 59-81.
21. Reddy DS, Kulkami, SK. The nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Prain Remarch I 799; L 215- L 229.
22. Dhingra D, Parle M, Kulkami SK. Effect of combination of insulin with dextrose, D- (-) -fructose and diet on learning and memory in mice. Indian Journal of Pharmacology 2003; 35: 151-156.
23. Sherry A. Ferguson 1 F, Javier Cisneros B, Joseph P, Hanig, Kimberly J. B. Chronic Oral Treatment with 13-cis-Retinoic Acid (Isotretinoin) or all-trans-Retinoic Acid Does Not Alter Depression-Like Behaviors in Rats. Toxicological Sciences, 2005; 87(2): 451-459.
24. ltoh J, Nabeshima T, Kameyarna T. Utility of an elevated plus maze for the evaluation of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 1990; 101: 27-33.
25. Cícero Francisco B. F, Sales K F, Barbosa 1 ALDR., Bezerra JNS, Manoel A N, Marta Maria de FF, and Glauce SD BV. Alterations in behavior and memory induced by the essential oil of Zingiber officinale Roscoe (ginger) in mice are cholinergic- dependent. Journal of Medicinal Plants Research 2008; 2(7): 163-170,
26. Jeffrey MG, Linda CK. Litwin, and Jeffrey BM. Behavioral evidence for fl-adrenoceptor subsensitivity after subacute antidepressant M 2-adrenoceptor antagonist Naunyn- Schmiedebergs Arch Pharmacol 1985; 329: 355- 358
27. Zafir A, Ara A, and Naheed B. In vivo antioxidant status: A putative target of antidepressant action Neuro- Psychopharmacology and Biological Psychiatry, 2009; 13(2): 220-228.
28. Furuzan YB, Faruk E, Güner TU, Nejat G. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology, 2000; 149:41
29. Fujimori H, Cobb D. Central nervous system depressant activity of MA 1337, 3-[3,4-m-clorophenyl-I-piperazyl)propyl)-2-qlH,3H) quinozolinedione hydrochloride. The Journal of Pharmacology and Experimental Therapeutics 1965; 148: 151-157.
30. Veronika EG, and David S. Effect of unavoidable shock on no aversively motivated performance physiological and behavior.1978; 21(6):877-881
31. Martin P, soubrie P, siman P. Noradrenergic and opioid medication of tricyclic- induced reversal of escape deficits cause by in escapable shock pretreatment in rat. Psychopharmacol, 1986; 90: 90-94.
32. Sherman MD, Allers GL, Petty F, Henna FA. A neuropharmacologically relevant animal model of depression. Neuropharmacology, 1979; 134; 265-367.
33. Onodera K, Yasumi O, and Kensuke K. Characteristics of muricide induced by thiamine deficiency and its suppression by antidepressants or intraventricular serotonin physiological and behavior.1981; 27(5):847-853.
34. Vogel H.G. "Drug Discovery and Evaluation- Pharmacological Assays", Second Completely Revised, Updated, and Enlarged Edition, published by Springer 2002, 478 -495
35. Rao SK, Andrade C, Reddy K, Madappa, KN, Thyagarajan S., Chandra S. Memory protective effect of indomethacin against electroconvulsive shock-induced rats. Biological psychiatry2002; 51: 770-773.
36. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychophar- macological 1986; 13: 222-257.
37. Hannah S, Rushton R, Tinson C. Modification of the effects of an amphetamine barbiturate mixture by the past experience of rats. Nature, 1961; 2: 533-535.